There has been a slight upward trend in vaccination coverage in younger age groups, Primary Health Care Secretary General Marios Themistokleous said in a recent press conference on 13 September.
To date, 140,000 children in the 12-17 age group have been vaccinated, authorities said.
40-44 years old: 65.5% are already vaccinated, and 66.3% upon doctor’s prescription. 35-39 years: 58.5% are vaccinated, and after appointments this figure reached 59%. 30-34: 58% were vaccinated, 59% when prescribed by a doctor. 25-29 years old: 57% have already been vaccinated, with a doctor’s appointment the figure has reached 58%. 18-24: 48% are vaccinated, and 49% upon a doctor’s prescription. 15-17: 25% have already been vaccinated, and when a doctor was prescribed this figure was 26.5% (90,000 children in this age group have already been vaccinated, 16,000 children have been vaccinated in recent days) 12-14 years: 13% are already vaccinated, and with a doctor’s appointment – 14.5% (50,000 children of this age category have already been vaccinated, 13,500 – in recent days)
Mr. Themistocleous announced that 6,265,000 citizens have been vaccinated with at least one dose, which corresponds to 60% of the total population and 68.6% of the adult population, while 5,850,000 citizens have completed the full vaccination cycle, which corresponds to 56% of the population. in general and 65% of the adult population.
“Don’t waste time in vain”
“It is a lie that vaccines interfere with the development of children or alter their DNA,” said Maria Theodoridou, President of the National Vaccination Committee, referring to the vaccination of young people aged 12-17 in the context of regular vaccination information. “Not a single day should be wasted, vaccinations should not be delayed. All questions will be answered by people who are trusted. ” That is, mostly pediatricians, who now also vaccinate in their clinics.
Ms Theodoridou noted that the mobility of young people aged 5 to 11 is increasing internationally, noting that “clinical trials are ongoing and the FDA, after filing an application in the coming months, may begin approval with an indication of their immediate use.”
“On the 3rd dose, the national committee gave a positive opinion on specific categories,” said Ms Theodoridou, noting that “the time interval for administering the 3rd dose is 6 to 8 months after the 2nd”.
Given that the process of prescribing a third dose of vaccine in certain populations is starting, Ms Theodoridou added that “the immune response data indicate that other populations may be able to defend themselves with a third dose, for example, if the body has been exposed to the effects of the virus “.
When asked about this, she said that it is too early to think about further increasing the vaccination groups for the 3rd dose. “We are waiting for scientific and epidemiological data to support the need for this,” she said.
“The antibody test seemed to be useful for research from the start, not for individual use,” she said in response to a related question.
Referring to those who avoided vaccinations due to excessive stress due to allergic reactions, she described a study in Israel, according to which 98% of participants had no reaction, 1% had a mild reaction, and only 0.7% had anaphylactic shock, immediately treatable. According to Ms Theodoridou, this study is important because it “reflects the risk of an allergic reaction in real conditions.”